EMEA-001581-PIP02-16
Key facts
| Active substance |
Solithromycin
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0120/2016
|
| PIP number |
EMEA-001581-PIP02-16
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of gonococcal infection
|
| Route(s) of administration |
|
| Contact for public enquiries |
Triskel EU Services
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|